Gorilla Mind Turk-Plex Review

No published batch Certificate of Analysis appears on the listing, and unlike Toniiq (#1) the product does not even make a third-party-testing claim — so the actual turkesterone content is taken purely on the brand's reputation. That's the single biggest mark against it, because adulteration and under-dosing are the documented failure of this entire category: independent labs have repeatedly found turkesterone products with under 1% of their labeled content. Turk-Plex is a credible, well-known product, but on the decisive criterion — verification — it asks for trust rather than offering proof.

Turkesterone is poorly absorbed on its own, and a hydroxypropyl-β-cyclodextrin inclusion complex is the most-cited approach to improving its bioavailability — the extract is essentially wrapped in a ring-shaped sugar molecule that helps carry it into solution. Turk-Plex was one of the products that popularized this route, and it's the strongest part of the formulation. Be clear on what it does and doesn't mean: better absorption of a compound is not the same as evidence that the compound works, and no human trial shows turkesterone builds muscle whether it's absorbed well or not.

They make opposite bets. Toniiq competes on standardization (20% from a 50:1 extract) and a stated third-party-testing claim, but uses no absorption complex. Turk-Plex competes on brand reputation and the cyclodextrin delivery system, at a lower 10% standardization and with no testing claim at all. Because verification is the decisive axis in this category, Toniiq edges ahead — but if you weight the cyclodextrin formulation and a known brand more heavily than the higher % and the testing claim, Turk-Plex is the rational pick.

At about $30 for 60 capsules (~$0.50 a serving) Turk-Plex is priced at the upper end of the standard 10% products, and you're paying for the brand name and the cyclodextrin complex rather than for verified content. If those two things matter to you, it's a defensible premium. If cost-per-serving is your priority, Double Wood (#4) and Nutricost (#3) deliver the same 10% standardization for materially less, and Nutricost at least states third-party testing. None of them, including Turk-Plex, posts a COA.

There's no good human evidence that it will. The 'natural anabolic' claim behind all turkesterone rests on rodent and in-vitro data plus one flawed study on ecdysterone — a different compound — whose supplement was later shown to be under-dosed. A 2025 randomized trial that assayed a commercial phytosteroid product found under 0.1% of the labeled active and no benefit over placebo. Turk-Plex's reputation and formulation are real; the proof that the ingredient works is not. Treat it as an experiment, not a guarantee.

1. [1] Phytosteroid labeling RCT 2025 PMID 40781783 — How reliable is the labeling of a commercial phytosteroid product? A 12-week randomized double-blind training study. Researchers assayed a commercial phytosteroid supplement and found the actual ecdysterone content was <0.1% of the label claim, with no hypertrophy in a cell model and no advantage over placebo in human training groups. Hard evidence that label numbers in this category can be almost entirely fictional — which is exactly why a posted COA, absent here, matters more than Turk-Plex's brand name or formulation.
2. [2] Parr 2014 PMID 24974955 — Estrogen receptor beta is involved in skeletal muscle hypertrophy induced by the phytoecdysteroid ecdysterone. A mechanistic rodent/in-vitro study: ecdysterone induced hypertrophy of rat soleus muscle fibers and increased C2C12 myotube diameter, apparently via estrogen-receptor-beta signaling. The kind of animal and cell data the 'natural anabolic' positioning is built on — biologically suggestive, but conducted on ecdysterone in rats and cells, not turkesterone in humans, and no substitute for clinical efficacy.
3. [3] Parr 2015 PMID 26060342 — Ecdysteroids: a novel class of anabolic agents?. A review by leading ecdysteroid researchers weighing whether ecdysteroids (including turkesterone) act as anabolic agents. It compiles supportive animal and in-vitro data and notes their marketing as natural anabolics, while making clear that rigorous human efficacy evidence was lacking — a balanced read of why the category is plausible-but-unproven, from the scientists closest to it.